Mark Rubinstein to Middle Aged
This is a "connection" page, showing publications Mark Rubinstein has written about Middle Aged.
Connection Strength
0.121
-
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial. Lancet Oncol. 2018 05; 19(5):694-704.
Score: 0.043
-
COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer. Cancer Cell. 2022 02 14; 40(2):117-119.
Score: 0.014
-
Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100426.
Score: 0.014
-
Differential immune signatures in the tumor microenvironment are associated with colon cancer racial disparities. Cancer Med. 2021 03; 10(5):1805-1814.
Score: 0.013
-
Distance telescopes: a survey of user success. Optom Vis Sci. 2000 May; 77(5):260-9.
Score: 0.013
-
Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer. J Hematol Oncol. 2017 04 07; 10(1):82.
Score: 0.010
-
Levels of visual impairment in a day centre for people with a mental handicap. J R Soc Med. 1991 Sep; 84(9):542-4.
Score: 0.007
-
Corneal epithelial oxygen uptake rate in diabetes mellitus. Eye (Lond). 1990; 4 ( Pt 5):757-9.
Score: 0.006
-
Pseudophakic accommodation? A study of the stability of capsular bag supported, one piece, rigid tripod, or soft flexible implants. Br J Ophthalmol. 1990 Jan; 74(1):22-5.
Score: 0.002